相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-Amyloid-β Immunotherapy in Alzheimer's Disease: Relevance of Transgenic Mouse Studies to Clinical Trials
Donna M. Wilcock et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Clinical and Research Diagnostic Criteria for Alzheimer's Disease
Marie Sarazin et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2012)
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
Pierre N. Tariot et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains
Jian-Quan Shi et al.
BRAIN RESEARCH (2011)
The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
Paula L. McClean et al.
JOURNAL OF NEUROSCIENCE (2011)
Exercise training increases size of hippocampus and improves memory
Kirk I. Erickson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline
Karin Yurko-Mauro et al.
ALZHEIMERS & DEMENTIA (2010)
Goal-Oriented Cognitive Rehabilitation for People With Early-Stage Alzheimer Disease: A Single-Blind Randomized Controlled Trial of Clinical Efficacy
Linda Clare et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimer's Disease
G. Maher-Edwards et al.
CURRENT ALZHEIMER RESEARCH (2010)
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease A Randomized Trial
Joseph F. Quinn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Putting brain training to the test
Adrian M. Owen et al.
NATURE (2010)
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease LEADe
H. H. Feldman et al.
NEUROLOGY (2010)
Dimebon disappointment
Roy W. Jones
ALZHEIMERS RESEARCH & THERAPY (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Results of the first-in-man study with the active Aβ Immunotherapy CAD106 in Alzheimer patients
Bengt G. Winblad et al.
Alzheimers & Dementia (2009)
Oral amyloid anti-aggregating agent ELND005 is measurable in CSF and brain of healthy adult men
Pamela Garzone et al.
Alzheimers & Dementia (2009)
Clinical trials of EHT 0202, a neuroprotective and procognitive alpha-secretase stimulator for Alzheimer's disease
Laurent Desire et al.
Alzheimers & Dementia (2009)
Effects of rosiglitazone as monotherapy in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease
Michael Gold et al.
Alzheimers & Dementia (2009)
Efficacy of a Vitamin/Nutriceutical Formulation for Moderate-stage to Later-stage Alzheimer's disease: A Placebo-controlled Pilot Study
Ruth Remington et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2009)
Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease
David B. Henley et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Secretase inhibitors and modulators for Alzheimer's disease treatment
Taisuke Tomita
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Reassessing the amyloid cascade hypothesis of Alzheimer's disease
Sanjay W. Pimplikar
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine
Joanne Rodda et al.
INTERNATIONAL PSYCHOGERIATRICS (2009)
Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease A Randomized Controlled Trial
Robert C. Green et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Vitamin E Paradox in Alzheimer's Disease: It Does Not Prevent Loss of Cognition and May Even Be Detrimental
Ana Lloret et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles
Kamila B. Kurakhmaeva et al.
JOURNAL OF DRUG TARGETING (2009)
Cognitive Training for Early-Stage Alzheimer's Disease and Dementia
Fang Yu et al.
JOURNAL OF GERONTOLOGICAL NURSING (2009)
Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease
Katy A. Chalmers et al.
JOURNAL OF NEUROLOGY (2009)
DEVELOPMENT OF AFFITOPE VACCINES FOR ALZHEIMER'S DISEASE (AD) - FROM CONCEPT TO CLINICAL TESTING
A. Schneeberger et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (vol 7, pg 779, 2008)
L. Lannfelt et al.
LANCET NEUROLOGY (2009)
Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests
K. A. Bates et al.
MOLECULAR PSYCHIATRY (2009)
18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
Norman R. Relkin et al.
NEUROBIOLOGY OF AGING (2009)
Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice
Xin-Kang Tong et al.
NEUROBIOLOGY OF DISEASE (2009)
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2009)
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
Mathew Blurton-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Long-term course and effectiveness of combination therapy in Alzheimer disease
Alireza Atri et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2008)
P4-346: Safety, tolerability and biomarker effects of an Abeta monoclonal antibody administered to patients with Alzheimer's disease
Eric R. Siemers et al.
Alzheimers & Dementia (2008)
Emerging and potential therapies for Alzheimer's disease
Heledd H. Griffiths et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
A feasibility and tolerability study of lithium in Alzheimer's disease
Alastair Macdonald et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Omega-3 supplementation in mild to moderate Alzheimer's disease:: effects on neuropsychiatric symptoms
Yvonne Freund-Levi et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease - A randomized trial
Nicola T. Lautenschlager et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Etazolate, a neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing
M. Marcade et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Hope in Alzheimer's fight emerges from unexpected places
Trisha Gura
NATURE MEDICINE (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
PPARγ agonists as therapeutics for the treatment of Alzheimer's disease
Gary Landreth et al.
NEUROTHERAPEUTICS (2008)
No Effect of One-Year Treatment with Indomethacin on Alzheimer's Disease Progression: A Randomized Controlled Trial
Danielle de Jong et al.
PLOS ONE (2008)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease:: a phase IIa, double-blind, randomised, placebo-controlled trial
Lars Lannfelt et al.
LANCET NEUROLOGY (2008)
Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity
Roberto Cappai et al.
NEUROCHEMICAL RESEARCH (2008)
The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial
Kenneth Rockwood et al.
BMC NEUROLOGY (2007)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Cholinesterase inhibitors reduce cortical Aβ in dementia with Lewy bodies
C. G. Ballard et al.
NEUROLOGY (2007)
Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid β-protein metabolism in mouse models of Alzheimer disease
Matthew L. Hemming et al.
NEUROBIOLOGY OF DISEASE (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Meta-analysis of six-month memantine trials in Alzheimer's disease
Rachelle Smith Doody et al.
ALZHEIMERS & DEMENTIA (2007)
A Phase II study targeting amyloid-β with 3APS in mild-to-moderate Alzheimer disease
P. S. Aisen et al.
NEUROLOGY (2006)
Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction
Susumu Kotani et al.
NEUROSCIENCE RESEARCH (2006)
ω-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease:: OmegAD study -: A randomized double-blind trial
Yvonne Freund-Levi et al.
ARCHIVES OF NEUROLOGY (2006)
Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model
JoAnne McLaurin et al.
NATURE MEDICINE (2006)
Antihypertensive medication use and incident Alzheimer disease - The Cache County Study
Ara S. Khachaturian et al.
ARCHIVES OF NEUROLOGY (2006)
Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial
K Rockwood et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease
MB Loeb et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
PN Tariot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Rofecoxib - No effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study
SA Reines et al.
NEUROLOGY (2004)
Neuroprotection by tetracyclines
M Domercq et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
RAGE (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid β-peptide clearance through transport across the blood-brain barrier
R Deane et al.
STROKE (2004)
GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila
A Mudher et al.
MOLECULAR PSYCHIATRY (2004)
Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia - Randomised controlled trial
A Spector et al.
BRITISH JOURNAL OF PSYCHIATRY (2003)
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial
PS Aisen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of Aβ42 in patients with Alzheimer's disease
C Hock et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2003)
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease - A pilot phase 2 clinical trial
CW Ritchie et al.
ARCHIVES OF NEUROLOGY (2003)
Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease
S Gauthier et al.
INTERNATIONAL PSYCHOGERIATRICS (2002)
分享论文
